Clinical Staging of Alzheimer’s Disease: Concordance of Subjective and Objective Assessments in the Veteran’s Affairs Healthcare System
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical Staging of Alzheimer’s Disease: Concordance of Subjective and Objective Assessments in the Veteran’s Affairs Healthcare System ; volume:11 ; number:3 ; day:1 ; month:7 ; year:2022 ; pages:1341-1352 ; date:9.2022
Neurology and Therapy ; 11, Heft 3 (1.7.2022), 1341-1352, 9.2022
- Creator
-
Morin, Peter
Li, Mingfei
Wang, Ying
Aguilar, Byron J.
Berlowitz, Dan
Tahami Monfared, Amir Abbas
Irizarry, Michael
Zhang, Quanwu
Xia, Weiming
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-022-00379-z
- URN
-
urn:nbn:de:101:1-2022101517303850781417
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Morin, Peter
- Li, Mingfei
- Wang, Ying
- Aguilar, Byron J.
- Berlowitz, Dan
- Tahami Monfared, Amir Abbas
- Irizarry, Michael
- Zhang, Quanwu
- Xia, Weiming
- SpringerLink (Online service)
Other Objects (12)
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer’s Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System
Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Staging of Alzheimer's disease based on MRI using CNN
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Alzheimer’s Disease
Correction to: Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer’s Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System
Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Staging of Alzheimer's disease based on MRI using CNN
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Alzheimer’s Disease
Correction to: Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer’s Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System
Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Staging of Alzheimer's disease based on MRI using CNN
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Alzheimer’s Disease
Correction to: Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis